Recombinant Bovine Prokineticin receptor 1 (PROKR1)

What is Bovine PROKR1 and what are its key characteristics?

Bovine Prokineticin Receptor 1 (PROKR1) is a G protein-coupled receptor that shares approximately 85% amino acid identity with PROKR2. This receptor is also known by several synonyms including PKR1, GPR73, GPR-73a, ZAQ, and PK-R1. PROKR1 functions primarily by binding prokineticins (particularly PROK1) to regulate various biological processes. The receptor is widely expressed in peripheral tissues, with particularly high expression in the gastrointestinal system, lungs, and blood system . PROKR1 has a higher binding affinity for PROK1 compared to PROKR2, which can influence downstream signaling specificity in different tissue contexts .

What signaling pathways are activated by PROKR1?

PROKR1 activates multiple signaling cascades upon ligand binding. The primary pathways include:

• Calcium mobilization

• Phosphoinositol turnover

• Activation of Akt kinase

• Mitogen-activated protein kinase (MAPK) pathway

While calcium mobilization is dependent on Gq proteins, the activation of MAPK pathways demonstrates sensitivity to pertussis toxin, suggesting that PROKR1 also couples to Gi proteins . In certain tissues like dorsal root ganglion neurons, PROKR1 activates transient receptor potential vanilloid 1 (TRPV1) channels through a pathway likely involving protein kinase C activation . This complex signaling network allows PROKR1 to mediate diverse cellular responses in different tissues.

What is the tissue distribution pattern of PROKR1 in bovine systems?

PROKR1 displays a distinctive tissue distribution pattern that differs from PROKR2. While PROKR2 is predominantly expressed in the central nervous system (particularly in the hypothalamus, olfactory ventricular regions, and limbic system), PROKR1 is more abundant in peripheral tissues . In the gastrointestinal system, PROKR1 is more abundantly expressed in the intestine compared to PROKR2, suggesting it may be the primary receptor mediating prokineticin effects on gastrointestinal motility. Additionally, PROKR1 expression has been detected in various endocrine tissues including thyroid, pituitary, adrenal gland, testis, and ovary , indicating its potential roles in hormone regulation.

How does PROK1-PROKR1 signaling affect corpus luteum function during different reproductive states?

PROK1-PROKR1 signaling demonstrates differential effects on corpus luteum (CL) function depending on the reproductive state. Research in porcine models has revealed significant impacts on steroidogenesis, cell survival, and angiogenesis. During early pregnancy (Day 12), PROK1 significantly upregulates the expression of steroidogenic genes including STAR and HSD3B1 (p<0.0001) in luteal explants, while also elevating CYP11A1 expression (p<0.05) . Interestingly, the same signaling pathway shows opposite effects on CYP11A1 expression during the estrous cycle, where PROK1 reduces CYP11A1 expression in CL explants collected on Day 12 (p<0.05) .

The effects on progesterone production also vary by reproductive state. PROK1 elevates progesterone concentration in:

• Day 12 of pregnancy (p<0.05)

• Day 14 of the estrous cycle (p<0.05)

• Day 14 of pregnancy (p<0.05)

These differential effects suggest that PROK1-PROKR1 signaling is modulated by the hormonal environment and may play distinct roles in CL maintenance during pregnancy versus the estrous cycle.

What is the relationship between PROKR1 activation and angiogenesis in reproductive tissues?

PROKR1 activation by PROK1 has significant pro-angiogenic effects in reproductive tissues, particularly in the corpus luteum. When PROK1 acts through PROKR1, it stimulates several key angiogenic processes:

• Increased formation of capillary-like structures by luteal endothelial cells

• Elevated expression of angiogenin genes

• Enhanced secretion of Vascular Endothelial Growth Factor A (VEGFA) by luteal tissue

The capillary-like structure formation assay using primary luteal endothelial cells isolated from corpus luteum on Day 12 of the estrous cycle demonstrated that PROK1 increases the numbers of nodes and junctions in the endothelial network . This suggests that PROKR1 activation promotes the reorganization of endothelial cells into vessel-like structures.

This angiogenic effect appears particularly important during the mid-luteal phase and early pregnancy, potentially contributing to the extended lifespan of the corpus luteum during pregnancy. The differential regulation of angiogenesis may be a key mechanism by which PROKR1 signaling supports the distinct vascular requirements of the corpus luteum in different reproductive states.

What are the optimal methods for quantifying recombinant Bovine PROKR1 expression?

For accurate quantification of recombinant Bovine PROKR1 expression, several complementary approaches should be employed:

• ELISA-based detection: Sandwich ELISA kits designed specifically for Bovine PROKR1 offer reliable quantification with a sensitivity of approximately 0.23ng/mL and a detection range of 0.937-60ng/mL . These assays are particularly useful for detecting PROKR1 in serum, plasma, tissue homogenates, cell lysates, and cell culture supernatants.

• Quantitative RT-PCR: For mRNA expression analysis, qRT-PCR provides high sensitivity. When designing primers, researchers should account for the various synonyms and potential splice variants of PROKR1 (including PKR-1, GPR73, ZAQ) to ensure specific amplification.

• Immunological detection methods: Western blotting and immunohistochemistry/immunofluorescence using validated antibodies allow for protein-level detection and localization studies. When using immunofluorescence, it is essential to include appropriate controls, such as normal IgG negative controls, to confirm antibody specificity .

• Radioligand binding assays: For functional studies of the receptor, radioligand binding assays using labeled prokineticins can determine receptor density and binding affinity.

For optimal results, researchers should validate their detection methods using positive controls (tissues known to express high levels of PROKR1, such as intestinal samples) and negative controls (tissues or cell lines with minimal PROKR1 expression).

How can researchers effectively design experiments to study PROKR1-mediated signaling in corpus luteum?

Designing effective experiments to study PROKR1-mediated signaling in corpus luteum requires a multi-faceted approach:

• Tissue collection timing: Given the dynamic expression of PROKR1 during different reproductive states, precise timing of tissue collection is crucial. For porcine models, days 10-14 of the estrous cycle and corresponding days of pregnancy are particularly informative for comparative studies .

• Ex vivo tissue culture systems: Precision-cut luteal slice in vitro models allow for controlled experimental manipulation while maintaining tissue architecture. These systems are particularly useful for studying the effects of PROK1 on gene expression and hormone production .

• Cell isolation and characterization: Isolation of primary luteal cells and luteal endothelial cells should be followed by thorough characterization. For luteal cells, confirmation of steroidogenic markers like HSD3B1 is essential. For endothelial cells, markers such as von Willebrand factor (vWF) should be confirmed .

• Functional assays:

  • Steroidogenesis: Measure gene expression of key enzymes (STAR, HSD3B1, CYP11A1) and progesterone production

  • Cell viability/apoptosis: FITC-Annexin V and propidium iodide staining

  • Angiogenesis: Capillary-like structure formation assays with primary luteal endothelial cells

• Receptor specificity controls: Include experiments with specific PROKR1 antagonists or siRNA-mediated knockdown to confirm receptor specificity of observed effects.

A comprehensive experimental design should incorporate time-course studies to capture the dynamic nature of PROKR1 signaling and dose-response analyses to characterize the sensitivity of different downstream pathways.

What analytical techniques are most effective for studying PROKR1-PROK1 binding interactions?

Studying PROKR1-PROK1 binding interactions requires specialized analytical techniques that can provide insights into binding affinity, kinetics, and structural determinants:

• Surface Plasmon Resonance (SPR): This label-free technique can determine association and dissociation rates (kon and koff) as well as equilibrium dissociation constants (KD) for PROK1-PROKR1 interactions. Recombinant PROKR1 can be immobilized on a sensor chip, and varying concentrations of PROK1 can be flowed over the surface.

• Isothermal Titration Calorimetry (ITC): ITC provides thermodynamic parameters of binding, including binding stoichiometry, enthalpy changes, and binding constants.

• Fluorescence-based binding assays: Using fluorescently labeled PROK1 or employing fluorescence resonance energy transfer (FRET) techniques can provide insights into binding dynamics in real-time.

• Radioligand binding assays: Classical competitive binding assays using radiolabeled ligands can determine binding affinities and receptor densities in various tissue preparations.

• Bioluminescence Resonance Energy Transfer (BRET): For studying PROKR1 interactions with downstream signaling molecules, BRET can be employed to monitor protein-protein interactions in living cells.

When conducting these analyses, it's important to consider that PROK1 has differential binding affinities for PROKR1 and PROKR2, with a higher affinity for PROKR1 . Therefore, comparative binding studies with both receptors can provide valuable insights into ligand selectivity determinants.

How should researchers interpret contradictory results in PROKR1 signaling studies?

Contradictory results in PROKR1 signaling studies are not uncommon and require careful interpretation. Several factors may contribute to seemingly conflicting findings:

• Reproductive state differences: PROKR1 signaling shows distinct effects depending on reproductive state. For example, PROK1 elevates CYP11A1 expression in corpus luteum during pregnancy but reduces it during the estrous cycle . Researchers should explicitly consider and compare reproductive states when interpreting results.

• Cell type-specific responses: PROKR1 can couple to different G proteins (Gq, Gi, Gs) depending on the cellular context , potentially leading to different signaling outcomes. Experiments should clearly identify the cell types being studied and avoid generalizing findings across different cell populations.

• Downstream pathway interactions: The complex interactions between different signaling pathways activated by PROKR1 may lead to context-dependent outcomes. Pathway-specific inhibitors can help dissect these interactions and resolve apparent contradictions.

• Species differences: Substantial variation in PROKR1 function exists across species. Research in porcine models shows PROK1-PROKR1 signaling is important during early pregnancy, while in bovine systems, strong expression occurs during luteal regression . Cross-species comparisons should acknowledge these differences.

• Methodological variations: Differences in experimental approaches, including ligand concentrations, exposure times, and assay readouts, can contribute to discrepant findings. Standardized protocols and comprehensive reporting of methods can help address this issue.

When confronted with contradictory results, researchers should consider these factors and design experiments that systematically explore the contextual determinants of PROKR1 signaling outcomes rather than viewing contradictions as experimental failures.

What are the key considerations when analyzing PROKR1 function in complex tissue environments?

Analyzing PROKR1 function in complex tissue environments presents unique challenges that require specific considerations:

• Cellular heterogeneity: Tissues like the corpus luteum contain multiple cell types (steroidogenic cells, endothelial cells, immune cells) that may respond differently to PROKR1 activation. Single-cell approaches or cell-specific isolation techniques should be employed to deconvolute cell type-specific responses.

• Paracrine interactions: PROKR1 activation may trigger the release of secondary mediators that act on neighboring cells. For example, PROK1 stimulates VEGFA secretion by luteal tissue , which can then influence surrounding cells. Analyzing both direct and indirect effects is essential for a comprehensive understanding of PROKR1 function.

• Temporal dynamics: PROKR1 expression and signaling effects vary throughout physiological processes like the estrous cycle. Time-course studies with appropriately spaced sampling points are necessary to capture these dynamics.

• Compensatory mechanisms: In complex tissues, inhibition or activation of PROKR1 may trigger compensatory responses through parallel signaling pathways. Combined interventions targeting multiple pathways may be needed to fully understand PROKR1's role.

• Ex vivo versus in vivo discrepancies: Findings from isolated cells or ex vivo tissue cultures may not fully recapitulate in vivo functions due to missing systemic factors. Validation using in vivo models with tissue-specific manipulations provides the most comprehensive insights.

Researchers should employ complementary approaches that bridge the gap between reductionist cell culture systems and complex in vivo environments, such as precision-cut tissue slices or organoid cultures that maintain tissue architecture while allowing experimental manipulation.

How reliable are current animal models for studying bovine PROKR1 function?

The reliability of animal models for studying bovine PROKR1 function varies based on several factors:

For optimal reliability, researchers should employ bovine-derived experimental systems whenever possible and validate findings across multiple experimental approaches. When using non-bovine models, careful consideration of species differences is essential for appropriate interpretation of results.

What are the emerging technologies that could advance PROKR1 research?

Several emerging technologies hold promise for advancing our understanding of PROKR1 biology:

• CRISPR-Cas9 gene editing: This technology enables precise modification of PROKR1 in primary bovine cells or even embryos, allowing for the creation of knockout or knock-in models to study receptor function. CRISPR-based approaches can also be used for high-throughput screening of PROKR1 regulatory elements.

• Single-cell multi-omics: Integrating single-cell RNA sequencing with proteomics and epigenomics can reveal cell type-specific PROKR1 expression patterns and signaling responses within heterogeneous tissues like the corpus luteum.

• Advanced tissue culture systems: Microfluidic organ-on-chip platforms and 3D organoid cultures can provide more physiologically relevant models for studying PROKR1 function while maintaining the complex cellular interactions present in vivo.

• Spatial transcriptomics and proteomics: These techniques allow for the visualization of PROKR1 expression and downstream signaling events with spatial resolution in intact tissues, providing insights into local signaling microenvironments.

• Optogenetic and chemogenetic approaches: These tools enable temporal control over PROKR1 activation, allowing researchers to study the dynamics of signaling with unprecedented precision.

• Cryo-electron microscopy: Structural studies of PROKR1 using cryo-EM could reveal the molecular determinants of ligand binding and receptor activation, potentially informing the development of selective modulators.

These technologies, particularly when used in combination, have the potential to overcome current limitations in PROKR1 research and provide more comprehensive insights into its functions in different physiological and pathological contexts.

What unresolved questions about PROKR1 warrant further investigation?

Despite significant advances in our understanding of PROKR1 biology, several important questions remain unresolved:

• Ligand selectivity mechanisms: Although PROK1 has higher affinity for PROKR1 than PROKR2 , the structural determinants of this selectivity are not fully understood. Detailed structural studies could reveal the molecular basis of ligand recognition and inform the development of receptor-selective compounds.

• Signaling pathway integration: PROKR1 activates multiple signaling pathways, including calcium mobilization, MAPK, and Akt , but how these pathways integrate to produce cell type-specific responses remains unclear. Systematic analysis of pathway crosstalk could provide insights into the context-dependent effects of PROKR1 activation.

• Reproductive state-dependent functions: The differential effects of PROKR1 signaling during pregnancy versus the estrous cycle suggest complex regulatory mechanisms that are not fully characterized. Identifying the factors that modulate PROKR1 signaling in different reproductive states could reveal new aspects of luteal function regulation.

• Therapeutic potential: The role of PROKR1 in processes like angiogenesis, steroidogenesis, and pain perception suggests potential therapeutic applications, but translational research in this area remains limited. Developing selective PROKR1 modulators and testing their effects in relevant disease models could reveal novel therapeutic strategies.

• Evolutionary conservation and divergence: Comparative studies across species could reveal conserved core functions of PROKR1 versus species-specific adaptations, providing insights into the evolutionary history and biological significance of this signaling pathway.

Addressing these questions will require interdisciplinary approaches combining molecular biology, structural biology, systems biology, and translational research.